Clinical Trials Directory

Trials / Completed

CompletedNCT01570452

Matrilysin Expression in Different Stages of Colorectal Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
38 (actual)
Sponsor
University of Roma La Sapienza · Academic / Other
Sex
All
Age
40 Years – 83 Years
Healthy volunteers
Accepted

Summary

Matrix metalloproteinases (MMPs) have been shown to be involved in cancer biology. Significant expression of MMP-7 (matrilysin) in colorectal cancer is mainly associated with metastatic disease even though it is expressed in most tumor states. Our purpose is to analyse MMP-7 in bowel and lymph nodes of different tumor stages and to evaluate its expression as a potential biomarker of cancer disease in patients surgically treated for benign and malignant colorectal tumors. Tumoral tissue, lymph nodes and serum samples from recruited Patients plus serum samples from healthy volunteers are analysed for matrilysin expression by histology, immunohistochemistry, ELISA and Western blotting. If Matrilysin increases with increasing dysplasia and cancer disease stage in tumor tissue as well as in the regional lymph nodes it might be used as a complement in investigating suspected locally advanced cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREcolonic or colorectal resectionstandard laparotomic resection of colon-rectum including right hemicolectomy, left hemicolectomy, sigmoidectomy, anterior resection

Timeline

Start date
2005-09-01
Primary completion
2008-09-01
Completion
2012-02-01
First posted
2012-04-04
Last updated
2012-04-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01570452. Inclusion in this directory is not an endorsement.